Monograph Details

Cardiovascular System > Edema
ACETAZOLAMIDE INJECTION
Manufacturer
Various generic manufacturers
Legal Classification
Rx
Pharmacological Class
Carbonic anhydrase inhibitor.
Generic Name
Acetazolamide 500mg/vial; pwd for inj after reconstitution; preservative-free.
Indications
Edema.
Children
Not recommended.
Adults
Give by IV inj. Edema: give 1–2 days on, 1 day off. 250mg–375mg once daily. CHF: 250–375mg once daily in the AM. Acute high altitude sickness: see literature.
Contraindications
Hypokalemia. Hyponatremia. Severe renal, hepatic, or adrenocortical impairment. Hyperchloremic acidosis. Cirrhosis. Chronic noncongestive angle-closure glaucoma. Sulfonamide allergy.
Precautions
Respiratory impairment. Renal calcium calculi. Diabetes. Gout. Monitor blood and electrolytes. Elderly. Pregnancy (Cat.C). Nursing mothers: not recommended.
Interactions
inhibits renal excretion of basic drugs and promotes excretion of acidic drugs. May increase toxicity of salicylates (acidosis), folic acid antagonists. Hypokalemia with corticosteroids, potassium wasting diuretics. Monitor phenytoin, primidone, antihyperglycemics, quinidine, lithium, cyclosporine. Antagonizes methenamine.
Adverse Reactions
Anorexia, drowsiness, confusion, malaise, depression, GI distress, paresthesias, tinnitus, acidosis, initial hypokalemia, hyperuricemia, transient myopia; renal calculi, nephrotoxicity, hepatic dysfunction, blood dyscrasias, rash, fever, photosensitivity (rare).
How Supplied
Contact supplier.
Additional Resources
Related Prescribing Note